Tilman Schneider-Hohendorf

Publications

• Natalizumab-associated PML: Challenges with Incidence, Resulting Risk, and Risk Stratification
  Neurology. Mar, 2017  |   Pubmed ID: 28228564
• CD62L Test at 2 Years of Natalizumab Predicts Progressive Multifocal Leukoencephalopathy
  Neurology. Nov, 2016  |   Pubmed ID: 27815407
• CD62L is Not a Reliable Biomarker for Predicting PML Risk in Natalizumab-treated R-MS Patients
  Neurology. Aug, 2016  |   Pubmed ID: 27572431
• Impaired NK-mediated Regulation of T-cell Activity in Multiple Sclerosis is Reconstituted by IL-2 Receptor Modulation
  Proceedings of the National Academy of Sciences of the United States of America. May, 2016  |   Pubmed ID: 27162345
• CD8(+) T-cell Pathogenicity in Rasmussen Encephalitis Elucidated by Large-scale T-cell Receptor Sequencing
  Nature Communications. Apr, 2016  |   Pubmed ID: 27040081
• Therapy with Natalizumab is Associated with High JCV Seroconversion and Rising JCV Index Values
  Neurology(R) Neuroimmunology & Neuroinflammation. Feb, 2016  |   Pubmed ID: 26848486
• CD4+ T Effector Memory Cell Dysfunction is Associated with the Accumulation of Granulocytic Myeloid-derived Suppressor Cells in Glioblastoma Patients
  Neuro-oncology. Jun, 2016  |   Pubmed ID: 26578623
• PML Risk Stratification Using Anti-JCV Antibody Index and L-selectin
  Multiple Sclerosis (Houndmills, Basingstoke, England). Jul, 2016  |   Pubmed ID: 26432858
• Neurocognitive Decline in HIV Patients is Associated with Ongoing T-cell Activation in the Cerebrospinal Fluid
  Annals of Clinical and Translational Neurology. Sep, 2015  |   Pubmed ID: 26401512
• Trafficking of Lymphocytes into the CNS
  Oncotarget. Jul, 2015  |   Pubmed ID: 26255669
• Assessment of Immune Functions and MRI Disease Activity in Relapsing-remitting Multiple Sclerosis Patients Switching from Natalizumab to Fingolimod (ToFingo-Successor)
  BMC Neurology. Jun, 2015  |   Pubmed ID: 26099927
• Therapeutic Uses of Anti-α4-integrin (anti-VLA-4) Antibodies in Multiple Sclerosis
  International Immunology. Jan, 2015  |   Pubmed ID: 25326459
• VLA-4 Blockade Promotes Differential Routes into Human CNS Involving PSGL-1 Rolling of T Cells and MCAM-adhesion of TH17 Cells
  The Journal of Experimental Medicine. Aug, 2014  |   Pubmed ID: 25135296
• Ultraviolet B Light Attenuates the Systemic Immune Response in Central Nervous System Autoimmunity
  Annals of Neurology. May, 2014  |   Pubmed ID: 24771567
• Specific Loss of Cellular L-selectin on CD4+ T Cells is Associated with PML Development During HIV Infection
  AIDS (London, England). Jan, 2014  |   Pubmed ID: 24445368
• L-Selectin is a Possible Biomarker for Individual PML Risk in Natalizumab-treated MS Patients
  Neurology. Aug, 2013  |   Pubmed ID: 23925765
• Immunological and Clinical Consequences of Treating a Patient with Natalizumab
  Multiple Sclerosis (Houndmills, Basingstoke, England). Mar, 2012  |   Pubmed ID: 21908480
• Volume Regulation of Murine T Lymphocytes Relies on Voltage-dependent and Two-pore Domain Potassium Channels
  Biochimica Et Biophysica Acta. Aug, 2011  |   Pubmed ID: 21575593
• Blockade of the Kinin Receptor B1 Protects from Autoimmune CNS Disease by Reducing Leukocyte Trafficking
  Journal of Autoimmunity. Mar, 2011  |   Pubmed ID: 21216565
• Regulatory T Cells Exhibit Enhanced Migratory Characteristics, a Feature Impaired in Patients with Multiple Sclerosis
  European Journal of Immunology. Dec, 2010  |   Pubmed ID: 21108477
• Temporal Pattern of ICAM-I Mediated Regulatory T Cell Recruitment to Sites of Inflammation in Adoptive Transfer Model of Multiple Sclerosis
  PloS One. 2010  |   Pubmed ID: 21085578